Clinical Trials Browser

INDUSTRY × CTL019 chimeric antigen receptor × Clear all

NCT03896854 2023-11-29

CART-19 T Cell in CD19 Positive Relapsed or Refractory Acute Myeloid Leukemia (AML)

Phase 1/2 Unknown

Other hematologic neoplasm

Leukemia, Myeloid, Acute

NCT02810223 2016-10-14

Efficacy of CART-19 Cell Therapy in B Cell Acute Lymphoblastic Leukemia

Phase 1 Unknown

LymphoidOther hematologic neoplasm

Precursor Cell Lymphoblastic Leukemia-Lymphoma